Glacier Bancorp (NYSE:GBCI) reported quarterly earnings of $0.72 per share which missed the analyst consensus estimate of $0.73 by 1.37 percent.
After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss
The FDA approved Fennec Pharmaceuticals Inc’s (NASDAQ:FENC) Pedmark to reduce the risk of chemo-induced ototoxicity in pediatric patients. Pedmark is indicated…
